Tiopronin for chronic Hep B

China Pharma Wins Approval of Hepatitis Drug
by: ChinaBio Today January 13, 2009

China Pharma Holdings, Inc. (CPHI.OB) received SFDA approval of a new product,
Tiopronin Enteric-Coated Capsules. Tiopronin Tis widely given as a treatment
for acute and chronic hepatitis B and to relieve drug-induced liver injury.
Because Tipronin can cause stomach irritation, limiting its use, China Pharma
has encased its Tiopronin capsules with an enteric coating to decrease stomach
mucosal irritation.
Tiopronin is listed in the National Medical Insurance Program, allowing
patients to obtain reimbursement for the drug.
China Pharma said that China has 30 million people who suffer from chronic
hepatitis B. Almost 10% of the population, approximately 120 million people,
carry the virus, one of the highest concentrations in the world. Revenues in
China from of liver protection drugs such as Tiopronin, are projected to reach
41 billion RMB ($6 billion) in 2008.
The company did not project revenues for the product.
China Pharma's main revenue drivers are PuSenOK, a newly approved generic form
of Aleve-D; Buflomedil, a treatment for peripheral blood vessel diseases;
Roxithromycin dispersible tablet, a macrolide antibiotic; and Bumetanide, a
newly approved diuretic that treats edema caused by heart disease and
hypertension.

[bberry]

thanks for the info, however, it seems this bit belongs somewhere on the stock market with someone trying to bump up a certain ticker..
FDA approval does not mean the release of this med on the market and whether if they are going to mass produce it or not.. FDA is a tough baby with play with.

anyway, please copy and paste on here information about this medicine, Tiopronin, and tell us what it does.

maybe yet another treatment that helps prevent DNA replication. nothing more

[cajim]

Fascinating info!  Thanks.